Chlorotrianisene

Chlorotrianisene

Chlorotrianisene
Systematic (IUPAC) name
1,1',1''-(2-chloroethene-1,1,2-triyl)tris(4-methoxybenzene); 11-chloro-4,13-dimethoxy-12-(p-methoxyphenyl)stilbene
Clinical data
Trade names Tace
AHFS/Drugs.com
Pregnancy
category
  • US: X (Contraindicated)
Legal status
  • Discontinued
Routes of
administration
Oral
Pharmacokinetic data
Protein binding 50 to 80%
Identifiers
CAS Registry Number  Y
ATC code G03
PubChem CID:
IUPHAR/BPS
DrugBank  Y
ChemSpider  Y
UNII  Y
KEGG  Y
ChEBI  Y
ChEMBL  N
Chemical data
Formula C23H21ClO3
Molecular mass 380.864 g/mol
 N   

Chlorotrianisene (trade name Tace) is a non-steroidal synthetic estrogen that was formerly used for the treatment of menopause, deficiencies in ovary function, and prostate cancer.[1][2]


References

  1. ^ Drugs.com: Chlorotrianisene
  2. ^ Yuen, B. H.; Pendleton, H. J.; Blair, S. (1977). "Efficacy of bromocriptine and chlorotrianisene in preventing postpartum lactation". Canadian Medical Association journal 117 (8): 919–921.